ArticleProceedings of the National Academy of Sciences of the United States of America2011

Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.

Dimitrios N Vatakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.